**Core Concept:** Ventilation strategies in patients with acute respiratory distress syndrome (ARDS) aim to optimize oxygenation while minimizing ventilator-induced lung injury. ARDS is characterized by diffuse alveolar damage, increased vascular permeability, and hypoxemia.

**Why the Correct Answer is Right:** The correct answer, **B. V-A ECMO (veno-arterial extracorporeal membrane oxygenation)**, is a life-saving modality in severe cases of ARDS where conventional ventilation fails to improve oxygenation. V-A ECMO provides extracorporeal oxygenation and carbon dioxide removal, bypassing the damaged lung parenchyma. It allows the patient's lungs to rest while improving oxygenation and decreasing the workload on the failing heart and lungs.

**Why Each Wrong Option is Incorrect:**

A. **Non-invasive ventilation (NIV) and high-frequency oscillatory ventilation (HFOV)** are not ideal choices in ARDS patients with poor oxygenation, as they may exacerbate lung injury and are less effective in severe cases.

C. **Invasive mechanical ventilation (IMV)** is necessary in ARDS patients, but not the correct choice if oxygenation remains poor despite appropriate adjustments.

D. **Inhaled nitric oxide (iNO)** is a selective pulmonary vasodilator that improves oxygenation by dilating pulmonary vasculature. However, it is not a primary mode of ventilation and is not as effective as V-A ECMO in severe cases of ARDS.

**Clinical Pearl:** In patients with severe ARDS, V-A ECMO is a crucial option to consider when traditional ventilation fails to improve oxygenation. It allows the lungs to rest, improves oxygenation, and decreases the workload on the heart and lungs.